Jeanne M. Regnante, is the chief health equity and diversity officer at the LUNGevity Foundation and chair of the Foundation’s Health Equity Council. Regnante’s primary objective is to secure the engagement and insights of vulnerable lung cancer communities by working with trusted community-based organizations and multiple healthcare stakeholders to achieve health equity and reduce disparities for all. Previous to this position, Regnante was the senior vice president of the Community Engagement for National Minority Quality Forum, where she launched and chaired the Diverse Cancer Communities Working Group (CWG), which continued to work to optimize cancer care, treatment, and inclusion in clinical trials for racial and ethnic minorities and medically underserved cancer populations. Regnante has enjoyed her 30+ years at Merck & Co., at which she led a company-wide strategy focused on diversity and inclusion in clinical research. Regnante has authored several peer-reviewed publications, book chapters, and blogs with stakeholder experts focused on notable practices throughout the cancer care continuum. Regnante was recently honored as a Cancer Health 2021 Change Maker.